Doximity shares are trading higher following better-than-expected Q4 financial results and issued Q1 2025 revenue guidance above estimates. Also, Evercore ISI Group maintained an In-Line rating and raised its price target from $28 to $29.
Portfolio Pulse from Benzinga Newsdesk
Doximity shares are trading higher following better-than-expected Q4 financial results and issued Q1 2025 revenue guidance above estimates. Evercore ISI Group maintained an In-Line rating and raised its price target from $28 to $29.
May 17, 2024 | 11:24 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Doximity shares are trading higher due to better-than-expected Q4 financial results and optimistic Q1 2025 revenue guidance. Evercore ISI Group raised its price target from $28 to $29.
The better-than-expected Q4 financial results and higher-than-estimated Q1 2025 revenue guidance are positive indicators for Doximity's future performance. Additionally, the raised price target by Evercore ISI Group further supports a positive outlook for the stock.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100